Adaptive Biotechnologies (ADPT) ex-officer plans cashless option share sale
A former officer of Adaptive Biotechnologies (ADPT), Harlan Robins, intends to sell 261,044 shares of common stock under Rule 144, valued at approximately $6.4 million. These shares were acquired as stock option compensation and will be sold via a cashless exercise and same-day sale …